An abridged general view illustrating the heterogenous impacts of the transcription factor FOSB on the malignant progression and platinum-based chemotherapeutic prognosis in NSCLC with varying genetic backgrounds of TP53 via selectively transcriptionally activating distinct target genes. The gene discussed is TP53; the disease is non-small cell lung carcinoma.